1. The IPO was priced at $17 per share, according to the report.
2. Evolent increased the number of shares in the offering from 10 million to 11.5 million.
3. The software company is selling all of the class A shares in the offering.
4. Evolent is now valued at approximately $950 million.
More articles on health IT:
5 top data breach trends for this year
3M releases ICD-10 translation tool
Plug-and-play in action at the Center for Medical Interoperability
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
